Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation. (Q54231805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

title

Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

Xiao-Jun Huang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

author name string

Yingjun Chang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

publication date

19 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

published in

Frontiers of medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

45-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow ino

24 March 2020

cites work

1 reference

12 December 2020

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings

1 reference

12 December 2020

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

12 December 2020

A clinical study of haploidentical transplantation using granulocyte colony-stimulating factor stimulating donor bone marrow

1 reference

12 December 2020

Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation

1 reference

12 December 2020

G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia

1 reference

12 December 2020

Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia

1 reference

12 December 2020

Combined transplantation of G-CSF primed allogeneic bone marrow cells and peripheral blood stem cells in treatment of severe aplastic anemia.

1 reference

12 December 2020

In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.

1 reference

12 December 2020

A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease

1 reference

12 December 2020

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

1 reference

12 December 2020

A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts

1 reference

12 December 2020

Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

1 reference

12 December 2020

Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation

1 reference

12 December 2020

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

1 reference

12 December 2020

Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia

1 reference

12 December 2020

Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children

1 reference

12 December 2020

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

1 reference

12 December 2020

HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase

1 reference

12 December 2020

The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT

1 reference

12 December 2020

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation

1 reference

12 December 2020

Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors.

1 reference

12 December 2020

Guidelines for the diagnosis and management of aplastic anaemia

1 reference

12 December 2020

Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia

1 reference

12 December 2020

Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients

1 reference

12 December 2020

IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation

1 reference

12 December 2020

Interferon-α in acute myeloid leukemia: an old drug revisited

1 reference

12 December 2020

High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation

1 reference

12 December 2020

Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome

1 reference

12 December 2020

Now everyone has a donor for HSCT

1 reference

12 December 2020

The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation.

1 reference

12 December 2020

Haploidentical hematopoietic transplantation: current status and future perspectives

1 reference

12 December 2020

Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.

1 reference

12 December 2020

High frequency of CD4 CD25- CD69 T cells is correlated with a low risk of acute graft-versus-host disease in allotransplants.

1 reference

12 December 2020

How I treat acquired aplastic anemia

1 reference

12 December 2020

A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia

1 reference

12 December 2020

Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center

1 reference

12 December 2020

Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies

1 reference

12 December 2020

Haploidentical transplantation for hematologic malignancies: where do we stand?

1 reference

12 December 2020

Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens

1 reference

12 December 2020

Haplo-BMT: which approach?

1 reference

12 December 2020

Combination of a haploidentical SCT with an unrelated cord blood unit: a single-arm prospective study.

1 reference

12 December 2020

Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.

1 reference

12 December 2020

Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers

1 reference

12 December 2020

Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia

1 reference

12 December 2020

Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignances

1 reference

12 December 2020

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.

1 reference

12 December 2020

Who is the best donor for a related HLA haplotype-mismatched transplant?

1 reference

12 December 2020

Non-traditional CD4 CD25-CD69 regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Interferon α: the salvage therapy for patients with unsatisfactory response to minimal residual disease-directed modified donor lymphocyte infusion

1 reference

12 December 2020

Haploidentical transplantation: the search for the best donor

1 reference

12 December 2020

Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multic

1 reference

12 December 2020

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

1 reference

12 December 2020

A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia

1 reference

12 December 2020

Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

"No donor"? Consider a haploidentical transplant

1 reference

12 December 2020

HLA disparity is not crucial for the survival rate and severity of chronic health conditions in adult recipients following family donor hematopoietic stem cell transplantation

1 reference

12 December 2020

A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia.

1 reference

12 December 2020

A retrospective comparison of BU-fludarabine and BU-CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCT.

1 reference

12 December 2020

Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality

1 reference

12 December 2020

Haploidentical stem cell transplantation in patients aged 50 yr and older with leukemia: similar outcomes compared to younger adults

1 reference

12 December 2020

Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study

1 reference

12 December 2020

Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/

1 reference

12 December 2020

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

1 reference

12 December 2020

Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.

1 reference

12 December 2020

Recipient expression of ligands for donor inhibitory KIRs enhances NK-cell function to control leukemic relapse after haploidentical transplantation.

1 reference

12 December 2020

Salvage chemotherapy followed by granulocyte colony-stimulating factor-primed donor leukocyte infusion with graft-vs.-host disease control for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem ce

1 reference

12 December 2020

Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation

1 reference

12 December 2020

Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets

1 reference

12 December 2020

Modern approaches to HLA-haploidentical blood or marrow transplantation

1 reference

12 December 2020

Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States

1 reference

12 December 2020

Guidelines for the diagnosis and management of adult aplastic anaemia

1 reference

12 December 2020

Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation

1 reference

12 December 2020

Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study.

1 reference

12 December 2020

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.

1 reference

12 December 2020

Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT.

1 reference

12 December 2020

Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation.

1 reference

12 December 2020

Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant.

1 reference

12 December 2020

Long-term outcomes of HLA-haploidentical stem cell transplantation based on an FBCA conditioning regimen compared with those of HLA-identical sibling stem cell transplantation for haematologic malignancies

1 reference

12 December 2020

Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update

1 reference

12 December 2020

Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study

1 reference

12 December 2020

Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation

1 reference

12 December 2020

Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Improved clinical outcomes of rhG-CSF-mobilized blood and marrow haploidentical transplantation compared to propensity score-matched rhG-CSF-primed peripheral blood stem cell haploidentical transplantation: a multicenter study.

1 reference

12 December 2020

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant

1 reference

12 December 2020

A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies

1 reference

12 December 2020

Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia

1 reference

12 December 2020

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.

1 reference

12 December 2020

Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant

1 reference

12 December 2020

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.

1 reference

12 December 2020

Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial

1 reference

12 December 2020

Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation

1 reference

12 December 2020

A review of hematopoietic cell transplantation in China: data and trends during 2008-2016.

1 reference

12 December 2020

Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed

1 reference

12 December 2020

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.

1 reference

12 December 2020

Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia

1 reference

12 December 2020

Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion

1 reference

12 December 2020

Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants

1 reference

12 December 2020

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.

1 reference

12 December 2020

10.1007/S11684-017-0595-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29675688 AND SRC:MED&resulttype=core&format=json

24 March 2020

1 reference